Loading
Loading…
Loading…
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Tender Value
₹5 L
EMD Value
₹10,000
Closing Date
29 Oct 2026, 6:00 pm
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
MSVP
RGKMCH KOLKATA 700004
SUPPLY OF MEDICINES/REAGENTS FOR HOSPITAL
2026_RGK_5077745_1
RGKH/MSVP/MEDICINE/04/2026-27
Open Tender
Medicines
Item Wise
R.G.KAR MEDICAL COLLEGE AND HOSPITAL
AS PER NIT
3 documents required · 3 mandatory
₹0
₹10,000
Yes
OFFICE OF THE MSVP RGKMCH
6 Oct 2026
6 Oct 2026
2 Nov 2026
6 Oct 2026
29 Oct 2026
8 Oct 2026
12 Oct 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | POLY –L-LYSIN SOLUTION 100 ML. | 1 | BOTTLE OF 100 ml. | - | - |
| 2 | PRIMARY ANTIBODY Bcl2, 3 ML | 1 | 3 ml. PACK | 65 | ₹65 |
| 3 | PRIMARY ANTIBODY Bcl6, 3 ML | 1 | 3 ml. PACK | 75 | ₹75 |
| 4 | PRIMARY ANTIBODY CD 10, 3 ML | 1 | 3 ml. PACK | 75 | ₹75 |
| 5 | PRIMARY ANTIBODY CD 117, 3 ML. | 1 | 3 ml. PACK | 75 | ₹75 |
| 6 | PRIMARY ANTIBODY CD 15, 3 ML | 1 | 3 ml. PACK | 75 | ₹75 |
| 7 | PRIMARY ANTIBODY CD20-L26 3 ML. | 1 | 3 ml. PACK | 75 | ₹75 |
| 8 | PRIMARY ANTIBODY CD 30, 3 ML | 1 | 3 ml. PACK | 75 | ₹75 |
| 9 | PRIMARY ANTIBODY CD 34 Q BEND 10, 3 ML | 1 | 3 ml. PACK | 75 | ₹75 |
| 10 | PRIMARY ANTIBODY CD 3-POLYCLONAL, 3 ML | 1 | 3 ml. PACK | 75 | ₹75 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 5.74 MB
BOQ_5175880.xls
BOQ • 0.33 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .